Quotient Science
Nottingham, United Kingdom
NCT Number: NCT07036458
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Looking for future studies?
Notify Me30 year–65 year
Male
Interventional
Phase 1
Nottingham, United Kingdom
The following blood, urine and faecal samples will be collected, and assessments performed, at specified time points
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will receive a single administration of 14C Epaminurad Oral Solution
Time frame: Baseline to Day 8
Collection of plasma, urine and faeces samples during time frame point
Time frame: Baseline to Day 8
Collection of plasma, urine and faeces samples during time frame point
JW Pharmaceutical
Industry
An Open-label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C Epaminurad in Healthy Male Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05134428
Healthy Male Adults, Male Contraception
Wollongong, New South Wales, Australia
View Trial DetailsNCT03342963
Healthy Male Adults
Fukuoka, Japan
View Trial DetailsNCT02650063
Healthy Male Adults
Kagoshima, Japan
View Trial DetailsNCT01983514
Healthy Male Adults
Oslo, Norway
View Trial Details